140 related articles for article (PubMed ID: 7588431)
1. Cyclosporin A, rapamycin and FK506 decrease prolactin release from rat pituitary cells in primary culture.
Wera S; Zheng L; Hooghe-Peters EL; Belayew A; Martial JA; Velkeniers B
Endocr Res; 1995 Aug; 21(3):623-33. PubMed ID: 7588431
[TBL] [Abstract][Full Text] [Related]
2. Rapamycin, FK506 and cyclosporin A inhibit human prolactin gene expression.
Wera S; Belayew A; Martial JA
FEBS Lett; 1995 Jan; 358(2):158-60. PubMed ID: 7530217
[TBL] [Abstract][Full Text] [Related]
3. Cellular signaling mechanisms for stimulation of growth hormone secretion and growth hormone primary transcripts by immunosuppressant agents, FK506 and cyclosporin A, in cultured rat pituitary cells.
Ohye H; Sato M; Murao K; Matsubara S; Tokuda M; Takahara J
Neuroimmunomodulation; 1998; 5(6):309-17. PubMed ID: 9762012
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of action of immunosuppressive agents: cyclosporin A, FK506, and rapamycin.
Bierer BE
Proc Assoc Am Physicians; 1995 Apr; 107(1):28-40. PubMed ID: 8630742
[No Abstract] [Full Text] [Related]
5. The immunosuppressive drugs cyclosporin A and FK506 inhibit calcineurin phosphatase activity and gene transcription mediated through the cAMP-responsive element in a nonimmune cell line.
Schwaninger M; Blume R; Oetjen E; Knepel W
Naunyn Schmiedebergs Arch Pharmacol; 1993 Nov; 348(5):541-5. PubMed ID: 7509460
[TBL] [Abstract][Full Text] [Related]
6. Modes of action of FK506, cyclosporin A, and rapamycin.
Morris R
Transplant Proc; 1994 Dec; 26(6):3272-5. PubMed ID: 7527964
[No Abstract] [Full Text] [Related]
7. Roles of peptidyl-prolyl cis-trans isomerase and calcineurin in the mechanisms of antimalarial action of cyclosporin A, FK506, and rapamycin.
Bell A; Wernli B; Franklin RM
Biochem Pharmacol; 1994 Aug; 48(3):495-503. PubMed ID: 7520696
[TBL] [Abstract][Full Text] [Related]
8. Effect of cyclosporin A, FK506 and rapamycin on proliferation and soluble IL-2 receptor release from mitogenically stimulated rat spleen cells.
Pockley AG; Williams S; Reid SD; Bowles MJ
Biochem Soc Trans; 1995 Nov; 23(4):615S. PubMed ID: 8654800
[No Abstract] [Full Text] [Related]
9. Cyclosporin A, FK506 and rapamycin: more than just immunosuppression.
Kunz J; Hall MN
Trends Biochem Sci; 1993 Sep; 18(9):334-8. PubMed ID: 7694398
[TBL] [Abstract][Full Text] [Related]
10. Invasive aspergillosis in mice immunosuppressed with cyclosporin A, tacrolimus (FK506), or sirolimus (rapamycin).
High KP; Washburn RG
J Infect Dis; 1997 Jan; 175(1):222-5. PubMed ID: 8985226
[TBL] [Abstract][Full Text] [Related]
11. Divergent effects of rapamycin on mouse and rat cells following mitogenic stimulation.
Olivera DL; Kaplan JM; Newman-Tarr T; Ruggieri EV; Badger AM
Clin Immunol Immunopathol; 1993 Sep; 68(3):357-62. PubMed ID: 7690317
[TBL] [Abstract][Full Text] [Related]
12. Osteoblastic differentiation is enhanced by rapamycin in rat osteoblast-like osteosarcoma (ROS 17/2.8) cells.
Ogawa T; Tokuda M; Tomizawa K; Matsui H; Itano T; Konishi R; Nagahata S; Hatase O
Biochem Biophys Res Commun; 1998 Aug; 249(1):226-30. PubMed ID: 9705862
[TBL] [Abstract][Full Text] [Related]
13. Effects of FK506 and rapamycin on excitation-contraction coupling in skeletal muscle fibres of the rat.
Lamb GD; Stephenson DG
J Physiol; 1996 Jul; 494 ( Pt 2)(Pt 2):569-76. PubMed ID: 8842013
[TBL] [Abstract][Full Text] [Related]
14. Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia.
Sharkey J; Butcher SP
Nature; 1994 Sep; 371(6495):336-9. PubMed ID: 7522303
[TBL] [Abstract][Full Text] [Related]
15. [Mechanism of action of the new immunosuppressants: cyclosporin A, FK 506 and rapamycin].
Rondeau E
Nephrologie; 1992; 13(3):137. PubMed ID: 1379348
[No Abstract] [Full Text] [Related]
16. Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin A.
Steiner JP; Connolly MA; Valentine HL; Hamilton GS; Dawson TM; Hester L; Snyder SH
Nat Med; 1997 Apr; 3(4):421-8. PubMed ID: 9095176
[TBL] [Abstract][Full Text] [Related]
17. Effects of immunosuppressive peptidyl-prolyl cis-trans isomerase (PPIase) inhibitors, cyclosporin A, FK506, ascomycin and rapamycin, on hair growth initiation in mouse: immunosuppression is not required for new hair growth.
Iwabuchi T; Maruyama T; Sei Y; Adachi K
J Dermatol Sci; 1995 Jan; 9(1):64-9. PubMed ID: 7537082
[TBL] [Abstract][Full Text] [Related]
18. Effects of immunosuppressant agents on growth hormone release and gene expression.
Ohye H; Sato M; Matsubara S; Ohyama T; Murao K; Takahara J
Endocr J; 1998 Apr; 45 Suppl():S93-6. PubMed ID: 9790238
[No Abstract] [Full Text] [Related]
19. Differential inhibition of cutaneous T-cell-mediated reactions and epidermal cell proliferation by cyclosporin A, FK-506, and rapamycin.
Duncan JI
J Invest Dermatol; 1994 Jan; 102(1):84-8. PubMed ID: 7507155
[TBL] [Abstract][Full Text] [Related]
20. The effect of cyclosporin A, FK506, and rapamycin on the murine chronic graft-versus-host response--an in vivo model of Th2-like activity.
Bundick RV; Craggs RI; Holness E
Clin Exp Immunol; 1995 Mar; 99(3):467-72. PubMed ID: 7533681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
